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Abstract
This study was designed to evaluate the nano–bio interactions between endogenous biothiols (cysteine and glutathione) with bio-
medically relevant, metallic nanoparticles (silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs)), in order to assess the
biocompatibility and fate of nanoparticles in biological systems. A systematic and comprehensive analysis revealed that the prepa-
ration of AgNPs and AuNPs in the presence of biothiols leads to nanoparticles stabilized with oxidized forms of biothiols. Their
safety was tested by evaluation of cell viability, reactive oxygen species (ROS) production, apoptosis induction and DNA damage
in murine fibroblast cells (L929), while ecotoxicity was tested using the aquatic model organism Daphnia magna. The toxicity of
these nanoparticles was considerably lower compared to their ionic metal forms (i.e., Ag+ and Au3+). The comparison with data
published on polymer-coated nanoparticles evidenced that surface modification with biothiols made them safer for the biological
environment. In vitro evaluation on human cells demonstrated that the toxicity of AgNPs and AuNPs prepared in the presence of
cysteine was similar to the polymer-based nanoparticles with the same core material, while the use of glutathione for nanoparticle
stabilization was considerably less toxic. These results represent a significant contribution to understanding the role of biothiols on
the fate and behavior of metal-based nanomaterials.
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Introduction
Metallic nanoparticles (NPs) such as silver and gold have been
employed in a wide range of products and applications in the
biomedical field owing to their remarkable physico-chemical
properties. Silver nanoparticles (AgNPs) are extensively used in
antimicrobial coatings for medical devices, wound dressing,
cosmetic products and food packaging due to their antimicrobi-
al, antiangiogenic and anti-inflammatory properties [1-5]. Bio-
medical applications of gold nanoparticles (AuNPs) range from
molecular imaging, targeted drug delivery, gene therapy, cancer
treatment or radio-sensitization and theranostics [1,4,6]. More-
over, AgNPs and AuNPs are among the most investigated engi-
neered nanomaterials for medical use. A search performed in
the Web of Science (WoS) database on November 11th 2018
using the search terms “nano*” and “medic*” yielded a total of
63,032 papers. Out of those, silver was reported in 6,004 papers
(9.5%) and gold in 8,757 (13.9%), revealing that these two
types of NPs alone are represented by almost one quarter of all
published studies on biomedical aspects of NPs (Figure S1 in
Supporting Information File 1). In addition to the increase of
papers reporting on the development of NPs for biomedical
uses, the WoS search showed that there are ample in vitro and
in vivo studies on the toxicity effects of AgNPs and AuNPs.
There are a number of studies indicating that AgNPs negatively
impact cell membranes, interfere with signaling pathways,
disrupt the cell cycle, and cause mitochondrial dysfunction, oxi-
dative stress, DNA damage and apoptosis [7-9]. Many reports
on AgNP toxicity attribute it fully or partially to dissolved or re-
leased ionic silver [10-16]. The dissolution of AgNPs in both
biological and in different environmental media has been
proven, although the rate and amount varies depending on the
AgNP characteristics determined by the size, stabilization and
the presence of other molecules [17]. Still, some studies have
discussed that AgNP toxicity cannot be explained solely by the
release of Ag+ ions into the system [18,19]. Studies on AuNP
toxicity provide conflicting results, with some authors claiming
no toxicity was found [20-25], while others reported adverse
effects caused by AuNPs [26-32]. Most likely, a mechanism of
their toxicity is the generation of reactive oxygen species (ROS)
and reactive nitrogen species (RNS) that trigger necrosis or apo-
ptosis [33]. So far, a general consensus regarding NP toxicity is
that their toxic effects cannot be conclusively defined, as the
mechanism of their action depends on their physico-chemical
properties (shape, size, charge, coating agents), but also on
the targeted cells, tissues and/or organisms as well as on
the type of testing itself [34-38]. Therefore, each individual
NP type must be tested on various cell cultures using standard-
ized and reliable assay protocols to adequately assess and
explain the effects [39]. Exposure to NPs may lead to their
uptake, translocation, and most likely, biotransformation within
the body.
It has been demonstrated that AgNPs and AuNPs can be
absorbed into systemic circulation via different routes [40-43].
Absorbed or intravenously applied NPs will accumulate in dif-
ferent body compartments [44-46]. AgNPs are prone to oxida-
tive dissolution in biological media and the released Ag+ reacts
with thiolate groups of sulfur-containing biomolecules [47],
which may lead to the formation of thiol-coated AgNPs [48].
New clusters consisting of Ag2S can be created from free Ag+
[47]. This process, known as sulfidation, affects AgNP behav-
ior in the biological system [49], most notably by reducing their
toxicity [47,50]. The binding of thiols to AuNP surfaces has
been well investigated [51-57]. As the most abundant intracel-
lular biothiols are cysteine (CYS) and glutathione (GSH), their
role in intracellular sulfidation and/or adsorption on the surface
of NPs should be considered during the evaluation of efficacy,
safety and behavior of AgNPs and AuNPs in vivo [47,58]. The
biological effects of GSH-coated AuNPs and the potential for
their biomedical use have been assessed [55-57]. However,
there are still many knowledge gaps regarding the interaction
between metal-based NPs and biothiols. The WoS search
revealed less than 5% of the papers were related to studies on
the nano–bio interface between biothiols and AgNPs or AuNPs
(Figure S1 in Supporting Information File 1).
To gain further insight into the effect of biothiols on safety or
toxicity of bioactive metallic NPs, this study aims to compre-
hensively investigate the mechanism of formation of AgNPs
and AuNPs in the presence of CYS and GSH and their subse-
quent toxicity effects. Murine fibroblast L929 cells were
selected as the in vitro model to study mammalian toxicity due
to their properties. This cell line is non-cancerous, spontaneous-
ly immortalized, and one of the oldest continuous cell lines that
can be properly maintained for a long time without being trans-
formed. Daphnia magna was used as the representative aquatic
organism model to evaluate ecotoxicity.
The comparison of the observed results with data published on
other AgNP and AuNP types, as well as the results obtained for
ionic Ag and Au forms, allowed for a better understanding of
the role of CYS and GSH in biotransformation and biological
effects of AgNPs and AuNPs. This study provided additional
information to overcome knowledge gaps related to the design
of safe and efficient AgNPs and AuNPs for biomedical uses.
Results and Discussion
Synthesis and characterization of
nanoparticles
For the synthesis of AgNPs and AuNPs, a common bottom-up
approach was applied using sodium borohydride as an agent to
reduce Ag+ and Au3+, respectively. The optimization of the
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Figure 1: 1H NMR spectra of the reaction mixture aliquots (5.6 mM cysteine, 56 mM NaBH4, and 5.6 mM AgNO3, in ultrapure water/D2O added)
taken at several time points. The arrows show how proton signals (for cysteine and cystine) change with time.
synthetic protocol was achieved by a series of experiments in
which the reaction conditions (i.e., temperature, mixing time
and rate, concentration of reactants) were carefully tested in
order to obtain small, spherical and stable NPs. The molar ratio
of the reactants [metallic salts]/[NaBH4]/[biothiol] were varied
as summarized in Tables S1 and S2 of Supporting Information
File 1. The particles were deemed unstable if they fully precipi-
tated after synthesis and could not be redispersed, otherwise
they were noted as stable. After each synthesis, the careful char-
acterization of stable NPs was performed by dynamic light scat-
tering (DLS), electrophoretic light scattering (ELS) and trans-
mission electron microscopy (TEM) techniques. The obtained
results showed that the molar ratio of reactants was more im-
portant for the successful preparation of stable NPs than all
other parameters and experimental conditions. With regard to
using CYS as a stabilizing agent, the results indicated that its
molar concentration should be approximately ten times lower
than the concentration of NaBH4, while GSH allowed for much
wider concentration ranges. In the case of molar ratio reducing
agent vs metallic salts, a larger excess of NaBH4 (>5 times) was
needed to obtain stable NPs. Finally, we selected a molar ratio
of [metallic salts]/[NaBH4]/[biothiol] = 1:10:1 for further work
as it resulted in a favorable NP size (≈10 nm) and long term
stability.
Nuclear magnetic resonance (NMR), as an excellent tool to de-
termine the interactions of small organic molecules with
metallic NPs, was applied to evaluate small changes in the
chemical environment around NPs, which resulted in chemical
shifts in the NMR spectra. Several studies have been published
that confirm the validity of this technique in confirming
thiol–NP interactions [51,59-61].
In a typical experiment, the mixture of a metallic salt (HAuCl4
or AgNO3), NaBH4, and CYS (as described above) was stirred
under argon in ultrapure water at room temperature for
90 minutes. The progress of the reaction was monitored by
1H NMR spectroscopy. Aliquots were taken from the reaction
mixture at selected time points and D2O was added (or a D2O-
filled capillary was used for a lock signal). Along with the
disappearance of the 1H NMR signals of the reactant (CYS), a
new set of proton signals of the product emerged (Figure 1). All
new signals were shifted downfield by approximately 0.2 ppm.
According to detailed 1H and 13C NMR analysis (see Figures
S2–S4 in Supporting Information File 1), we conclude that
cystine was formed.
After completion (no CYS signals in 1H NMR spectrum) the
remaining signals were broadened in time, which indicates the
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Figure 2: 1H NMR spectra of the reaction mixture aliquots (5.6 mM glutathione, 56 mM NaBH4, and 5.6 mM HAuCl4, in ultrapure water/D2O added)
taken at several time points. The arrows show how proton signals (for GSH and GSSG) change with time.
binding of cystine to the NP surface. It is well known that
1H NMR signals from ligands bound to NPs display broad line
widths [62-64].
Exactly the same 1H NMR profile was recorded for the reac-
tion mixture which consisted of cysteine and NaBH4, i.e., no
metallic salt was added (see Figure S4 in Supporting Informa-
tion File 1). This means that during the regular procedure for
the cysteine-coated NPs synthesis (as described elsewhere), the
cystine may be formed prior to its binding to the NP surface. It
was shown earlier that cysteine in the reaction with metallic salt
(HAuCl4) underwent dimerization to form cysteine [65]. How-
ever, no NMR evidence was provided for that. In our case, the
dimerization occurred in the reaction mixture consisting of
NaBH4 and cysteine. It is possible that some NaBH4 hydrolysis
products [66-68] induce this dimerization, but the detailed
mechanism underlying the reaction was out of the scope of this
paper.
The very similar result was observed in the case of GSH which
undergoes dimerization to GSSG in the presence of Au3+ (or
Ag+) salt and NaBH4 (a standard protocol for the NPs synthe-
sis) (Figure 2), or in the presence of NaBH4 alone (see Figure
S5 in Supporting Information File 1). In conclusion, this indi-
cates that both biothiols (GSH and CYS) bind to the NP sur-
faces in their oxidized form, which supports some earlier
reports [51,69].
A detailed characterization of the prepared NPs dispersed in
ultrapure water (UPW) revealed a negative surface charge. The
observed zeta-potential values (Table 1) were indicative of a
high NP stability, as the NPs are generally considered electro-
statically stabilized when the absolute values of the zeta poten-
tial exceed 30 mV [70]. The size distribution of all NPs was
bimodal and the AgNPs were generally smaller than the AuNPs
(Table 1). TEM experiments showed a spherical shape for all
NPs (Figure 3).
As the biological effect resulting from interaction with metallic
NPs may originate from the release of metallic ions in the bio-
logical environment, it was important to evaluate the dissolu-
tion behavior of the NPs. The release of Ag+ and Au3+ ions
from AgNPs and AuNPs surfaces was studied in UPW and
media relevant for biological experiments (i.e., EMEM +
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Table 1: Hydrodynamic diameter (dH) and zeta potential (ζ) of silver (AgNPs) and gold (AuNPs) nanoparticles stabilized with cysteine (CYS) or
glutathione (GSH). The dissolution behavior was evaluated in ultrapure water (UPW), the cell culture medium used for L929 cells (EMEM) and the
medium used for cultivation of Daphnia magna (SCM) after 24 h.
Nanoparticles dH [nm] (% mean volume) ζ [mV] % free metal ions
UPW EMEM SCM
CYS AuNPs 10.6 ± 2.4 (41%)
36.3 ± 8.6 (59%)
−46.8 ± 2.1 no dissolution
CYS AgNPs 8.0 ± 0.9 (100%) −56.9 ± 7.5 0.13 0.22 0.26
GSH AuNPs 7.4 ± 2.1 (38%)
65.1 ± 13.8 (62%)
−58.0 ± 3.8 no dissolution
GSH AgNPs 6.0 ± 1.2 (100%) −50.9 ± 2.3 0.10 0.77 0.64
Figure 3: Transmission electron micrographs of silver (AgNPs) and gold nanoparticles (AuNPs) prepared in the presence of cysteine (CYS) or
glutathione (GSH).
10% FBS used as a culture media for fibroblasts and standard
culture media (SCM) used for D. magna). As expected, the
AuNPs did not dissolve in any of the tested media, while both
CYS- and GSH-coated AgNPs released more ions in the media
used for biological experiments (EMEM + 10% FBS and SCM)
compared to UPW (Table 1). However, the amount of free Ag+
measured after incubation of AgNPs in these media for 24 h did
not exceed 1% of total Ag. This does not necessarily mean that
the Ag+ release is negligible, since underestimation of ionic Ag
could happen due to complexes formed with components of the
tested media that can precipitate or cannot pass the filter.
Safety assessment
The toxicity of CYS- and GSH-coated AgNPs and AuNPs on
mammalian cells was investigated in vitro to determine if
biothiol-functionalization of metallic NPs reduces or increases
their safety. For this purpose, the efficiency of NP uptake, cell
viability, apoptosis induction, oxidative stress response and
genotoxicity parameters of L929 cells treated with prepared
NPs were determined and compared with control cells.
A range of NP concentrations were tested for negative effects
on the survival and viability of L929 cells after 24 h exposure.
Additional experiments included treatment of cells with differ-
ent concentrations of Ag+ (in the form of AgNO3) and Au3+
(applied as HAuCl4) to determine if toxicity effects originate
from the released counter ions. The results, as presented in
Figure 4, demonstrated dose-dependent toxic effects of CYS-
and GSH-coated AgNPs, while AuNPs showed no toxicity in
the tested concentration range (1–300 mg Au L−1). However,
GSH-coated AuNPs decreased cell viability by 20% at a dose of
300 mg Au L−1.
The GSH-coated AgNPs decreased cell viability by more than
50% at a dose 5 times lower than CYS-coated AgNPs. Ionic
silver was the most toxic and destroyed the cells at 10 times
higher dose compared to Au3+ (Figure 4a). Evidently, the most
lethal tested substance was Ag+ followed by GSH-coated
AgNPs. If we compare these results with data published on
polymer-coated AgNPs and AuNPs (see Table S3 in Support-
ing Information File 1), the toxicity of GSH-AgNPs is similar to
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Figure 4: (a) Viability of L929 cells exposed to silver (AgNPs) and gold nanoparticles (AuNPs) stabilized with cysteine (CYS) or glutathione (GSH),
Ag+ and Au3+ ions during 24 h and determined by the MTT cytotoxicity assay. (b) The effect of AgNPs, AuNPs, Ag+, and Au3+ on the number of live
(white columns), early apoptotic (dotted columns) and late apoptotic (blue columns) L929 cells after 24 h exposure, determined by flow cytometry
after Annexin V/PI staining. (c) The effect of AgNPs, AuNPs, Ag+, and Au3+ on the level of peroxy radical (white columns, as measured by DCFH-DA
assay) and total GSH (blue columns, as measured by MBCl assay) in L929 cells after 4 h of exposure. Negative controls (neg) were untreated cells.
Positive controls (pos) were cells treated with DMSO for MTT and Annexin V/PI assays, or with the t-butylhydroxyde for DCFH and MBCl assays. The
results are expressed as percentage of negative controls and given as mean values obtained from three independent experiments. Standard devia-
tions are presented as scale bars. Values marked with asterisk (*) differ significantly from the negative control (P < 0.05).
the toxicity effect of polyvinylpyrrolidone (PVP) stabilized
AgNPs on the same cell type as reported earlier [71,72]. The
PVP-coated NPs were selected for comparison as PVP is one of
the most frequently used coating materials for stabilization of
AuNPs and AgNPs [73]. Our results on AuNP cellular toxicity
corroborate well with a similar study on L929 cells treated with
PVP-coated AuNPs [74].
Dissolution experiments revealed that GSH-coated AgNPs
at a concentration of 25 mg Ag L−1 would release only
0.2 mg Ag+ L−1 in the cell culture media, the concentration of
ionic Ag that is non-toxic to L929 cells. Thus, the toxicity
mechanism is much more complicated than a simple metal ion
release in cell culture media. The cellular internalization of NPs
by active transport may lead to intracellular NP dissolution,
which may trigger a cascade of different toxic actions.
Further safety tests were performed using a concentration range
of NPs or ions that did not cause a decrease of cell viability by
more than 80%. Uptake of all tested NPs, as determined by flow
cytometry, showed dose-dependent cell penetration except for
the GSH-AuNPs (Figure S6 in Supporting Information File 1).
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Figure 5: The NP uptake within L929 cells (a–d) compared to untreated control cells (e–h) as visualized by reflection mode confocal laser scanning
microscopy (CLSM). The images show maximum intensity Z-projections of cells stained with phalloidin to stain actin and visualize cell cytoskeleton
(green), nucleic acid staining using Hoechst 33258 fluorescent dye (blue) and CLSM reflectance signals (red). The overlay of fluorescence stains and
segmented reflectance signals are given in (g,h). The control cells show no high intensity reflective spots (g), while NP reflectance signals are visible
as bright red signals and indicated by white arrows (c,d).
The highest efficiency of cell uptake was observed for CYS-
coated AuNPs. For both CYS- and GSH-coated AgNPs, the
uptake was significant only at the highest examined concentra-
tion (25 mg Ag L−1). The behavior of GSH AuNPs deviates
considerably from the others and did not show any significant
change in the side scattered light (SSC) ratio even at the highest
dose applied, indicating no cell accumulation. The flow cytom-
etry results on NP uptake were confirmed by visualization per-
formed using confocal laser scanning microscopy (CLSM) in
the reflection contrast mode. In cells treated with CYS-AgNPs,
GSH-AgNPs and CYS-AuNPs, accumulated NPs were clearly
visible intracellularly, while it was not possible to detect such
accumulation in the case of treatment with GSH-AuNPs (see
Figure 5 and Figure S7 in Supporting Information File 1). This
is in accordance with recently published in vivo data on GSH-
coated gold nanoclusters with promising theranostic properties
[55,56]. Our GSH-AuNPs bypassed internalization by L929
cells similar to the interaction of GSH-protected Au nanoclus-
ters with the reticuloendothelial system (RES) observed in these
studies, which demonstrated that GSH played a protective role
for AuNP-based theranostic systems against RES accumulation.
Moreover, the conducted pharmacokinetic studies revealed that
the use of GSH for the preparation of small AuNPs enhance
tumor retention time, but also increased normal tissue clear-
ance [55,56]. However, our results indicated a completely dif-
ferent interaction of CYS-AuNPs with non-cancerous L929
cells. The cell uptake clearly followed a dose-response pattern
(Figure S6 in Supporting Information File 1), while confocal
imaging showed the accumulation of CYS-AuNPs even in the
cell nucleus (Figure 5), which can explain their genotoxicity
and apoptosis induction ability (see discussion below).
To gain better insight into the toxicity mechanism of silver and
gold NPs and their counter ions, the percentage of live, early
apoptotic and late apoptotic/dead cells were determined by flow
cytometry analysis after staining with CAM and EthD dyes.
The doses that caused low or no significant reduction in cell
viability (Figure 4a) showed apoptotic processes in a dose-
response manner for all tested species (Figure 4b). In accor-
dance with the MTT data (Figure 4a), ionic species triggered
apoptosis in 86% and 95% of cells at the highest concentrations
applied, i.e., 1 mg Ag L−1 and 25 mg Au L−1, respectively.
Silver and gold NPs were safer, inducing at tested doses less
than 20% of apoptotic events (Figure 4b). However, treatment
with GSH-AuNPs led to a significant number of late apoptotic
cells, while CYS- and GSH-coated AgNPs were shown to be
safer than expected. In both cases, more than 88% of fibro-
blasts survived the treatment with the highest dose applied
(10 mg Ag L−1).
As the exposure to NPs is known to induce oxidative stress in
cells [75,76], ROS production and intracellular GSH levels
were measured after 24 h incubation with the tested species.
The results corroborated well with those on the number of
apoptotic cells. In all cases where doses of tested induced apo-
ptosis in fibroblasts, ROS levels were also significantly changed
(Figure 4c). The ROS level was significantly increased after
treatment with AgNPs and ionic metal species, but significant-
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Figure 6: The effect of silver (AgNPs) and gold nanoparticles (AuNPs) stabilized with cysteine (CYS) or glutathione (GSH), Ag+ and Au3+ ions on
(a) total DNA damage and (b) DNA double-stranded breaks (white columns), the activation of ATM (grey columns) and H2A.X (striped columns) in
L929 cells after 24 h exposure, measured with MuseTM Multi-Color DNA Damage Kit. Negative controls (Neg) were untreated cells, while positive
controls (pos) were cells treated with DMSO. The results are expressed as the percentage of negative controls and given as mean values obtained
from three independent experiments. Standard deviations are presented as scale bars. The values marked with an asterisk (*) differ significantly from
the negative control (P < 0.05).
ly decreased in the AuNP-treated cells, possibly due to more the
effective activation of protective mechanisms against oxidative
stress under these exposure scenarios [77]. A previous study on
human pulmonary fibroblasts also found that AuNPs cause
higher oxidative stress than AgNPs [78]. The level of GSH
changed significantly compared to the control only in cases
where the number of apoptotic cells was higher than 40%, i.e.,
cells treated with Au3+ or Ag+. Once more, the NPs were
proven to be less toxic than their ionic counterparts, requiring
10–50 times higher doses to achieve the same toxic effect.
As oxidative stress may induce damage to DNA molecules [79],
which will consequently lead to apoptosis if severe enough, the
DNA damage signaling pathway was evaluated by detecting the
ataxia–telangiectasia mutated (ATM) and H2A histone
(H2A.X) activated cells, as well as their dual activation which
indicates DNA double-strand breaks. DNA double-strand
breaks may lead to chromosome aberrations, genomic insta-
bility, or cell death [80]. The evaluation of ATM and H2A.X
activation is more accurate and is a quantitative measurement of
DNA damage response at the single cell level. The total per-
centage of damaged cells is a sum of ATM positive, H2A.X
positive and double-positive cells. Although the number of cells
positive for DNA damage was low (Figure 6), a clear dose-de-
pendent activation for each target was observed. In the case of
ionic forms, the number of cells with DNA damage increased
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Table 2: Acute toxicity of ionic silver and gold, silver (AgNPs) and gold nanoparticles (AuNPs) stabilized with cysteine (CYS) or glutathione (GSH), to
Daphnia magna Straus. EC50 values, no adverse observed adverse effect levels (NOAEL) and lowest observed adverse effect levels (LOAEL) are
given in µg Ag or Au L−1 and expressed as mean values obtained from 6 experiments and include standard deviations, while 95% confidence inter-
vals are given in parentheses.
Species examined EC50 (95% CI) NOAEL LOAEL
24 h 48 h 24 h 48 h 24 h 48 h
CYS-AgNP 347.6 ± 5.39 (344.19–364.39) 193.1 ± 5.20 (192.73–206.39) 50 20 100 50
GSH-AgNP 152.5 ± 6.20 (150.76–166.14) 119.0 ± 5.79 (116.92–131.31) 50 12 75 50
CYS-AuNP – – 2500 250 5000 500
GSH-AuNP – – 75 25 100 50
Ag+ 1.06 ± 5.69 (0–12.75) 0.97 ± 5.13 (0–11.74) 0.1 <0.1 0.5 0.1
Au3+ 12.7 ± 6.23 (12.15–27.61) 10.4 ± 6.19 (8.63–24.01) 5 4 7 5
with the increase of Au3+ or Ag+ concentration, while opposite
trends were observed in cells treated with NPs (Figure 6).
This could be the result of the higher mortality of the cells
exposed to larger concentrations of AgNPs and AuNPs,
lowering the overall number of cells with activated ATM and
H2A.X. It is important to note that the total percentage of cells
with DNA damage remains below 7% in all of the cases. Thus,
the overall harmful effect of AgNPs and AuNPs on DNA was
relatively small for the tested concentration range and duration
of exposure (24 h), as evidenced also by evaluation of apopto-
sis and oxidative stress response.
In general, ionic species were found to be the most toxic, fol-
lowed by AgNPs, while AuNPs can be considered safe to cells.
With regard to the effects of the coating, the results are incon-
clusive. The GSH-AgNPs decreased cell viability at a lower
concentration than CYS-AgNPs, but there were no significant
differences between these two treatments for the induction of
apoptosis, DNA damage or oxidative stress response. In the
case of AuNPs, CYS-AuNPs were slightly more toxic than
GSH-AgNPs with regard to cell viability, the number of cells in
late apoptosis, and DNA damage, which can be explained by
efficient internalization of these type of AuNPs (Figure 5,
Figures S6 and S7 in Supporting Information File 1). The GSH-
AuNPs proved to be not only less toxic than CYS-AuNPs, but
even demonstrated lower activation of ATM and H2A.X than in
control cells. However, the detailed mechanism behind these
results should be investigated in future studies.
When comparing the toxicity of CYS- or GSH-coated NPs with
those of the same core shell (Au or Ag) but coated with other
types of stabilization agents, it may be concluded that CYS-
AuNPs and GSH-AuNPs demonstrated low or even no toxicity
as other types of AuNPs [74]. The toxicity of CYS-AgNPs was
similar to other types of AgNPs [71], while GSH-AgNPs were
demonstrated to be the most toxic type of AgNPs. However,
this comparison only took into account the results published on
the L929 cell line (Table S3 in Supporting Information File 1).
As AuNPs demonstrated to be resistant to dissolution behavior
in cell culture media, the increased toxicity of GSH-AgNPs
may originate from the possible catalytic role of GSH on the
dissolution process on the AgNP surface. Indeed, GSH-AgNPs
released the highest amount of metallic ions in the culture
media (Table 1), while additional dissolution may also be ex-
pected in endosomes following cell uptake.
Acute toxicity test on D. magna
The ecotoxicological impact of CYS- and GSH-coated AuNPs
and AgNPs was tested using aquatic crustacean D. magna
Straus as a model organism due to its ecological significance
and widespread use in regulatory testing [81]. Acute toxicity
tests were performed after 24 and 48 h of exposure to NPs,
while treatment with Ag+ and Au3+ was included for compara-
tive purposes (Table 2).
The obtained EC50, no adverse observed adverse effect levels
(NOAEL) and lowest observed adverse effect levels (LOAEL)
values demonstrated significantly higher toxicity to Ag+ and
Au3+ compared to AgNPs. It was not possible to determine the
EC50 value for AuNPs, as the NOAEL and LOAEL values
reached g L−1 levels for both CYS- and GSH-coated AuNPs.
The CYS-AgNPs were slightly less toxic to D. magna than
GSH-AgNPs. Indeed, the trend for toxicity potential of the
tested ionic and nanoparticulate forms of Au and Ag were simi-
lar for aquatic organism as for mammalian cells. However, the
concentrations that caused harmful effects were much lower in
aquatic toxicity tests.
The microscopic evaluation of treated and survived D. magna
was additionally performed to assess if any accumulated NPs
can be found in the digestive tract of these animals. Deposits of
NPs, but also of ingested ionic Ag, were visible as black dots
(Figure 7). No traces of Au3+ were found. These micrographs
Beilstein J. Nanotechnol. 2019, 10, 1802–1817.
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Figure 7: Micrographs of D. magna neonates after 48 h exposure to ionic and nanoparticulate forms of Ag and Au. Visible accumulation is marked
with arrows.
evidenced that D. magna was exposed to NPs through diges-
tion. Such results manifest the harmful environmental effects of
metallic NPs, as already evidenced in earlier studies [82-84].
The comparison of these results with previously published tox-
icity data on polymer- or citrate-coated AgNPs and AuNPs indi-
cated that functionalization with CYS- or GSH-reduced the NP
toxicity towards D. magna (see Table S4 in Supporting Infor-
mation File 1).
Conclusion
As the interest in metallic nanoparticles for biomedical use
grows, the need emerges for the development of safe, surface-
modified nanosystems. For the first time, safety profiling of
AgNPs and AuNPs prepared by using cysteine and glutathione
as stabilizing agents was performed. A careful and comprehen-
sive evaluation of physico-chemical properties and surface
modification of these NPs revealed that stabilization of both
AgNPs and AuNPs occurred through interaction of the metallic
nanosurface with disulfide of oxidized forms of cysteine and
glutathione. This important observation sheds new light on the
mechanism of NP formation in the presence of biothiols.
The in vivo assessment of NP toxicity on aquatic organisms ev-
idenced that surface modification of metallic NPs with bio-
thiols made them safer for the environment, while in vitro ex-
periments on mammalian cells demonstrated that AgNPs and
AuNPs functionalized with glutathione had a significant biolog-
ical impact. An increased toxicity effect was observed for the
AgNPs prepared in the presence of GSH, but a decreased toxici-
ty was observed in the case of AuNPs. Further studies should be
directed toward transformation patterns of NPs in vivo and the
role of nano–bio interactions that may either lead to less or
more toxic-transformed nanospecies.
Materials and Methods
Chemicals and reagents
All chemicals and materials were purchased from Sigma
Aldrich (Darmstadt, Germany) unless stated otherwise. Silver
nitrate (AgNO3) was purchased from Alfa Aesar (Karlsruhe,
Germany). All compounds were reagent-grade or higher.
Synthesis and characterization of
AgNPs and AuNPs in the presence of CYS
and GSH
AgNPs and AuNPs were synthesized by the reduction of silver
and gold salts, respectively, using sodium borohydride in the
presence of CYS or GSH as stabilizing agents. Several synthe-
tic approaches were tested, where different experimental param-
eters were employed (concentration and ratio of reactants,
ordering of reactants addition, mixing time and speed, etc.) as
presented in Tables S1 and S2 given in Supporting Information.
All syntheses were performed at room temperature and the mix-
tures were protected from light. The obtained NPs were care-
fully characterized by means of size distribution and surface
charge employing dynamic light scattering (DLS) and elec-
trophoretic light scattering (ELS) methods. The visualization of
the NPs was performed using TEM. The most stable AuNPs
and AgNPs with similar physico-chemical properties were ob-
tained by a procedure in which appropriate amounts of HAuCl4
or AgNO3 were dissolved in ultrapure water (UPW). The
biothiol solutions (CYS or GSH) were then added and stirred
for 10 min. Finally, NaBH4 was added dropwise under vigorous
stirring. The mixture was left to react for 2 h. The molar ratio of
[metallic salt]/[reducing agent]/[biothiol] = 1:10:1 was chosen.
For AuNPs, the final concentration of reagents was 3 mM
HAuCl4, 30 mM NaBH4 and 3 mM biothiol, while 5.6 mM
AgNO3, 56 mM NaBH4 and 5.6 mM biothiol were employed
for AgNPs. After the synthesis, each of the NP solutions were
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washed twice with UPW using ultracentrifugation at 15000g for
40 min. The washed NPs were kept in the dark at 4 °C.
The concentration of AgNPs and AuNPs was determined as the
total Ag and Au content, respectively, analyzed by an Agilent
Technologies 7800 inductively coupled plasma mass spectrom-
eter (ICPMS) (Agilent, Waldbronn, Germany). Visualization
was performed using a TEM 902A instrument (Carl Zeiss
Meditec AG, Jena, Germany). The microscope was operated in
the bright-field mode and at an acceleration voltage of 80 kV.
The TEM samples were prepared on a Formvar®-coated copper
grid (SPI Supplies, West Chester, PA, USA) by depositing a
drop of the particle suspension and leaving it to air-dry at room
temperature. The images were recorded with an attached Canon
PowerShot S50 camera. Both DLS and ELS measurements
were performed at room temperature using a Zetasizer Nano ZS
instrument (Malvern Instruments, Malvern, UK) with a green
laser (532 nm), set at an angle of 173°. The size distribution of
the NPs is expressed as the hydrodynamic diameter (dH) ob-
tained from the size-volume distribution function and given as
an average of 10 measurements. The surface charge was deter-
mined by measuring the electrophoretic mobility, which was
converted to zeta potential (ζ) values using the Henry equation
with the Smoluchowski approximation. The measurements were
repeated five times. The DLS and ELS data processing was per-
formed using Zetasizer software 6.32 (Malvern Instruments,
Malvern, UK).
The dissolution behavior of AuNPs and AgNPs was tested by
ultrafiltration followed by quantification of released free gold or
silver ions. The test media were UPW, cell culture medium
EMEM with the addition of 10% FBS, and standard culture
media for Daphnia magna cultivation (SCM). Freshly prepared
NPs were diluted in the test media to a final concentration of
10 mg L−1, and were left stirring in the dark for 1 h following
filtration using an Amicon-4 Ultra centrifugal filter of 3 kDa
cut-off size (Merck Millipore, Darmstadt, Germany). The ob-
tained filtrates were immediately acidified with HNO3 to a final
acid content of 10% (v/v). The released silver or gold ions were
quantified by ICP-MS. The reliability of the employed analyti-
cal method was confirmed using the Standard Reference Mate-
rial® (SRM) 1643e Trace Elements in Water (NIST, Gaithers-
burg, Maryland, USA). The results are presented as average
values of five independent measurements.
NMR experiments
The progress of the reaction in the mixture of biothiols, metallic
salts, and/or NaBH4, was followed by 1H and 13C NMR spec-
troscopy using a Varian INOVA 400 spectrometer (Varian, Palo
Alto, CA, USA) operating at 399.6 and 99.9 MHz, respectively.
The samples were prepared in UPW with the addition of D2O to
a final volume ratio of 10%, or in some cases, a capillary filled
with D2O was used as an external lock. 1H NMR spectra were
recorded in 10–20 min intervals during the NP synthesis,
starting immediately after the mixing of reagents (t0). The
chemical shifts were expressed in parts per million (ppm) and
are referenced to the residual water signal. All spectra were re-
corded at 25 °C. For all experiments, a recycle delay of 5 s was
used, which was sufficiently greater than the relaxation time T1.
To suppress the solvent signal, the WET and PRESAT pulse se-
quences were used, as available in VnmrJ (4.2A) software.
Cell experiments
Murine fibroblast (NCTC clone L929) cells (ATCC® CCL-
1TM) were cultured in EMEM with the addition of FBS (10%)
and penicillin/streptomycin (1%) in a T25 culture flask (Eppen-
dorf, Hamburg, Germany). The cells were regularly tested for
absence of mycoplasma by means of a direct DNA dye test
[85]. When the cells reached 80% confluence, the culture medi-
um was removed with a pipette; the cells were washed once
with sterile phosphate buffer saline (PBS), detached from the
flask by adding trypsin/EDTA (0.25%) solution and incubated
for 10 min at 37 °C and 5% CO2. The detached cells were
collected, counted on a TC20 automated cell counter (Biorad,
Invine, CA, USA), and seeded in sterile 96-well plates or
12-well plates (Eppendorf, Hamburg, Germany) for subsequent
treatment. The seeded cells were grown for 24 h at 37 °C and
5% CO2 to allow cell attachment. The following day, AgNPs,
AuNPs, AgNO3 and HAuCl4 were added to the wells in differ-
ent concentrations and treated for 24 h.
The MTT assay, based on the reduction of the yellow tetra-
zolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide) to a purple MTT-formazan crystal by meta-
bolically active cells, was used to determine cell viability after
24 h exposure. The assay was performed according to the
manufacturer’s instructions. Briefly, the cells were seeded in
96-well tissue culture plates (5 × 104 cells/mL growth medium,
i.e., 1.5 × 104 cells/cm2) followed by an overnight incubation.
The different concentrations of NPs or salt suspensions were
added (to a final concentration range of 1–100 mg L−1 for
AgNPs, 1–300 mg L−1 for AuNPs) and left to incubate for 24 h.
For the purpose of comparison, the cells were also incubated
with AgNO3 and HAuCl4, in the final concentration range of
0.1–50 mg L−1. The untreated cells were used as negative
controls, while the cells treated with dimethyl sulfoxide
(DMSO) (10% (v/v)) were used as positive controls. After incu-
bation, the medium was removed from the wells by aspiration;
the cells were washed three times with PBS (200 μL per well)
and MTT solution (50 μL, 1000 mg L−1) was added to each
well. The dye was left to incubate for 4 h at 37 °C, after which
the MTT solution was removed by aspiration. The remaining
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formazan crystals were dissolved by addition of DMSO (50 μL)
and shaking the plates. The absorbance was recorded at 530 nm
using a VictorTM multilabel reader (Perkin Elmer, Massachu-
setts, USA).
The ratio of live, apoptotic and dead cells after treatment with
NPs or respective metal salts was determined by flow cytom-
etry experiments using Annexin V and 7-aminoactinomycin D
(7-AAD) staining. Annexin V binds phosphatidylserine, which
can only be found on the outer leaflet of cell membranes during
apoptosis, while 7-AAD is a DNA-binding agent that cannot
penetrate the membrane of living cells and can only stain dead
or late apoptotic ones. The treatment involved 24 h incubation
of cells with AgNPs (ranging between 1–10 mg Ag L−1),
AuNPs (50–300 mg Au L−1), AgNO3 (0.1–1 mg Ag L−1) and
HAuCl4 (1–25 mg Au L−1) in 6-well plates at a density of
2.5 × 105 cells/well, i.e., 2.6 × 105 cells/cm2. Positive controls
were cells treated with paraformaldehyde (0.04 mg L−1), while
untreated cells were negative controls. After treatment, the
plates were centrifuged at 1500g for 15 min. Supernatants con-
taining dead cells were collected from 12-well plates in 1.5 mL
Eppendorf tubes. Live cells were detached from the wells by
adding 0.05 % GibcoTM trypsin/EDTA (Thermo Fisher Scien-
tific, Waltham, USA) solution, washed with PBS, resuspended
in PBS-based buffer containing FBS (2%) and EDTA
(2 mmol L−1) (pH 7.4, filtered through 0,2 μm sterile filter) and
passed through a 40 μm FalconTM cell strainer (Thermo Fisher
Scientific, Waltham, USA). The supernatants and the detached
cells were joined, centrifuged at 800g for 5 min and washed
with PBS containing 2% bovine serum albumin (1 mL per sam-
ple). The cells were then stained using Muse® Annexin V and a
dead cell assay kit (Merck KGaA, Darmstadt, Germany) ac-
cording to the manufacturer’s instructions. After staining, the
cells were washed twice by adding PBS (1 mL per sample) and
analyzed using a MuseTM cell analyzer along with the corre-
sponding MuseTM software module. The data are expressed as
percent relative to negative controls.
The internalization of the NPs was evaluated using a Molecular
ProbesTM LIVE/DEADTM kit (Invitrogen, Thermo Fisher
Scientific, Waltham, USA) and an Attune® acoustic focusing
flow cytometer (Applied Biosystems, Carlsbad, CA, USA)
equipped with a 488 nm laser. For the experiment, L929 cells
were seeded in 6-well plates at a density 2.5 × 105 cells/well.
After 48 h, the culture medium was exchanged with a fresh one
and increasing concentrations of AgNPs (1, 5 or 25 mg Ag L−1)
or AuNPs (25, 50 or 100 mg Au L−1) were added. Negative
controls were non-treated cells. The dissociated cells were incu-
bated with calcein acetoxymethyl ester (CAM, 0.1 µM) and
ethidium homodimer-1 (EthD, 3 μM), both supplied in the kit,
for 15 min in the dark at room temperature. Each experiment
was repeated at least three times. CAM and EthD were
measured using log amplifiers. The percentage of NP-labelled
cells was determined using the Attune acoustic focusing
cytometer by measuring the increase of the SSC of the laser
beam. The intensity of the SSC is proportional to the intracel-
lular density and granularity [86]. As NP uptake increases the
intracellular density, the SSC intensity is also enhanced. The
results were analyzed by FCS Express 5 Flow Cytometry Soft-
ware using Overton the cumulative histogram subtraction
method [87].
The reflection contrast mode of CLSM, as excellent non-inva-
sive imaging strategy for label-free real-time tracking
and quantification of non-fluorescent NPs [88], was used to
visualize cellular uptake of NPs. In brief, the cells were grown
in a 12-well chamber with glass slides (Eppendorf, Hamburg,
Germany). After treatment with AgNPs or AuNPs (at
5 mg Ag/Au L−1), the cells were washed with PBS, fixed with
ice-cold methanol (−20 °C), and stained with F-actin-phalloidin
and Hoechst 33258 nucleic acid dyes. The slides were then
mounted in Fluoroshield Antifade Mounting Medium and their
images were recorded using a Leica TCS-SPE CLSM (Leica,
Munich, Germany).
ROS production in cells treated with AgNPs and AuNPs was
determined by the 2′,7′-dichlorodihydrofluorescein diacetate
(DCFH-DA) staining. DCFH-DA is a non-fluorescent dye that
can freely permeate the cell membrane. Inside the cell, it is
hydrolyzed by cellular esterases to form DCFH, which is
then oxidized by intracellular ROS to fluorescent 2′,7′-dichloro-
fluorescein (DCF). After treatment of L929 cells with
AgNPs (in concentration range 1–5 mg Ag L−1), AuNPs
(10–100 mg Au L−1), AgNO3 (0.1–1 mg Ag L−1) and HAuCl4
(1–25 mg Au L−1) for 4 h at 37 °C, the cells were washed three
times with PBS and stained with DCFH-DA (20 μM) for
30 min at 37 °C. Then, the cells were washed again with PBS
two times and analyzed using a VictorTM multilabel reader
(Perkin Elmer, Hopkinton, MA, USA) at an excitation wave-
length of 485 nm and emission wavelength of 535 nm. The
untreated cells were used as negative controls, while cells
treated with hydrogen peroxide (100 μM) served as positive
controls. The data are expressed as percentage of fluorescence
intensity compared to negative controls.
The changes in the intracellular level of GSH were measured
using monochlorobimane (MBCl) staining. This fluorogenic
bimane probe forms a fluorescent adduct with GSH [89]. The
treatment of the cells was performed following the same
protocol as for the DCFH-DA assay, and the same controls
were used. After treatment, the cells were washed three times
with PBS, incubated with MBCl (50 μM) for 20 min at 37 °C,
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washed again twice with PBS and analyzed using a VictorTM
multilabel reader at an excitation wavelength of 355 nm and
emission wavelength of 460 nm. The data are expressed as per-
centage of fluorescence intensity compared to negative controls.
DNA damage in L9292 cells was assessed using the MuseTM
Multi-Color DNA Damage Kit (EMD Millipore, Merck, Darm-
stadt, Germany) according to the manufacturer’s instructions.
The kit measures the activation of ATM and H2A.X by phos-
phorylation, using phospho-specific ATM (Ser1981)-PE and
phospho-specific histone H2A.X-PECy5 conjugated antibodies.
This kit simultaneously provides statistical data for each of the
two critical DNA damage markers at the single-cell level. The
percentages of negative (undamaged) cells, ATM activated
cells, H2A.X activated cells and DNA double strand breaks
(dual activation of both ATM and H2A.X) were counted on the
MuseTM Cell Analyzer along with the corresponding MuseTM
software module.
Each cell experiment was repeated at least three times. The
L929 cells were used between 10 and 18 passages for all experi-
ments.
Additionally, the evaluation of interference between NPs and
each assay was carried out for different concentrations of
AgNPs and AuNPs (1, 10, 50 and 100 mg Ag L−1 or 1, 10, 50,
100 and 300 mg Au L−1, respectively) in cell-free culture medi-
um following protocols as defined by the assay producers. The
testing of interference with MTT, DCFH-DA and MBCl assays
was carried out in 96-well plates using a VictorTM plate reader
following protocols as described previously [90]. As the inter-
ference of AuNPs and AgNPs with these assays stems exclu-
sively from the optical properties of the NPs, interference was
avoided by eliminating NPs from the test system using careful
washing steps of the cells after treatment and before the staining
procedures as indicated in the cell protocols.
In the case of flow cytometry experiments, the settings on the
flow cytometer were carefully established taking into account
testing of the correct NP concentration range, system noise, and
evaluation of SSC signals that may be triggered by NPs. The
highest concentration of each NP solution was run first to set
the range for the maximum SSC signal. Gate settings for each
experiment were performed using several different positive and
negative controls, including NPs with and without dyes,
unstained untreated cells, and stained untreated cell. Due to
their small size, all AgNPs and AuNPs had a completely differ-
ent scattering pattern than the L929 cells, and were easily gated
out for elimination of background interference. To diminish
interference that may arise from false signals of labelled NPs
that could have been uptaken by live cells, we applied several
washing steps to the NP-treated cells before the staining proce-
dures.
Acute toxicity test on Daphnia magna
Acute ecotoxicity tests were performed on D. magna Straus, an
aquatic model organism for ecotoxicity tests. D. magna Straus
clone MBP996 was purchased as Toxkit Ephippia (MicroBio-
Tests Inc., Mariakerke, Belgium). Dormant eggs (ephippia)
were incubated in standard culture media (SCM) prepared as
reconstituted hard water with the addition of CaCl2·2H2O
(294 mg L−1), MgSO4·7H2O (123.25 mg L−1), NaHCO3
(64.75 mg L−1), and KCl (5.75 mg L−1) at pH 7.8 ± 0.5, with-
out any organic compounds. HRN EN ISO 6341:2013 protocol
and Toxkit Ephippia supplier instructions for handling were fol-
lowed. The exposure was carried out in the dark and the tem-
perature was maintained between 19 and 21 °C.
The concentrated stock solutions of AgNPs, AuNPs,
AgNO3 and HAuCl4 were diluted in the SCM to concentrations
ranging between 5–1000 mg Ag L−1, 5–5000 mg Au L−1,
0.1–10 mg Ag L−1 and 0.5–50 mg Au L−1, respectively. The
properties of the SCM such as temperature, pH, conductivity
and oxygen levels were assessed using the respective probes
from Orion Research Inc. (Jacksonville, FL, USA) at the start
and end of the experiment. Groups of five D. magna neonates
(24 h old) were transferred into glass test vessels that contained
10 mL of SCM (control) or tested compounds diluted in the
SCM. Great care was taken during the transfer to avoid
damaging any daphnids, which would lead to false conclusions.
The daphnids were incubated for 24 and 48 h without feeding
during the treatment period. The tests were performed four
times each in four replicates. The death of the D. magna organ-
ism was the endpoint of the test. The acute toxicity was
expressed as EC50, which is the effective concentration that
causes mortality of 50% daphnids, with a 95% confidence
interval (CI). The NOAEL and LOAEL were also recorded. In
addition, surviving and normal daphnids were inspected by light
microscopy to visualize the accumulation of Ag or Au in the
gut. After 48 h of treatment, the daphnids were washed with PB
pH 7.4 and put on microscopic glass using cover slips mounted
with Vectashield (Vector Laboratories, Burlingame, CA, USA).
An Opton III RS fluorescence microscope (Opton Feintechnik,
Oberkochen, Germany) with ×10 magnification was used for
examination and the images were recorded with a Spot RT
Slider camera (Diagnostic Instruments, Sterling Heights, MI,
USA). The image processing was performed in Adobe Photo-
shop 6.0.
Statistical analysis
Statistical analysis was carried out using DellTM StatisticaTM
13.2 software (StatSoft, Tulsa, USA). The data represent mean
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values with standard deviations. The differences between treat-
ments for the different measured variables were tested using
simple and repeated measures ANOVA, followed by Fisher
LSD post-hoc test when significant differences were found
(P < 0.05). The homogeneity of variances was tested using the
Levene test. The level of significance (P < 0.05) is indicated by
the asterisks (*) for differences between treatments and
controls.
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